• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of innovative antibacterial drugs targeting bacterial tyrosine kinases

Research Project

Project/Area Number 16K08341
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Drug development chemistry
Research InstitutionNational Institute of Infectious Diseases

Principal Investigator

Fukazawa Hidesuke  国立感染症研究所, 品質保証・管理部, 主任研究官 (10218878)

Project Period (FY) 2016-04-01 – 2020-03-31
Project Status Completed (Fiscal Year 2019)
Budget Amount *help
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2018: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2017: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2016: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
Keywordsチロシンキナーゼ / 細菌型チロシンキナーゼ / スクリーニング / タンパク質間相互作用 / BY-kinase
Outline of Final Research Achievements

Bacteria have tyrosine kinases that have no similarities to eukaryotic protein kinases. Although the functions of bacterial tyrosine kinases have not been fully revealed, their inhibitors are expected to become new antibacterial drugs because bacterial tyrosine kinases play essential roles in biosynthesis and transport of capsular polysaccharide and are closely related to pathogenicity. In this study, we successfully expressed active S. aureus tyrosine kinase in a human cell line. By fusing fluorescent protein tags to each of the catalytic subunit and regulatory subunit, we succeeded in visualizing the interaction between both subunits and revealed that the interaction and the kinase activation are strongly correlated. Various mutants were prepared, and sites important for enzyme activity and interaction were identified. We also established an inhibitor screening system for bacterial tyrosine kinases.

Academic Significance and Societal Importance of the Research Achievements

細菌にもチロシンリン酸化酵素は存在し、病原性と深く関わっているが、真核生物のプロテインキナーゼとは類似性がなく、その阻害剤は選択性の高い新しい抗菌薬になることが期待されている。しかし簡便な測定法がなく、阻害剤開発は進んでいない。本研究では黄色ブドウ球菌のチロシンキナーゼをヒト培養細胞株に発現させ、酵素活性の検出と触媒-調節サブユニット間相互作用の可視化に成功した。この方法は従来法よりもはるかに簡便に酵素学的性質の解析や阻害剤探索を行うことが可能であり、新規抗菌物質の開発に役立つことが期待される。

Report

(5 results)
  • 2019 Annual Research Report   Final Research Report ( PDF )
  • 2018 Research-status Report
  • 2017 Research-status Report
  • 2016 Research-status Report
  • Research Products

    (4 results)

All 2020 2019

All Journal Article (2 results) (of which Peer Reviewed: 2 results,  Open Access: 2 results) Presentation (2 results)

  • [Journal Article] Reconstitution of Bacterial Tyrosine Kinase-Modulator Interaction in a Human Cell Line2020

    • Author(s)
      Fukazawa H, Fukuyama M, Miyazaki Y.
    • Journal Title

      BPB Reports

      Volume: 3 Pages: 28-33

    • NAID

      130007944891

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Expression of Active <i>Staphylococcus aureus</i> Tyrosine Kinases in a Human Cell Line2019

    • Author(s)
      Fukazawa, H., Fukuyama, M., Miyazaki, Y.
    • Journal Title

      Biological and Pharmaceutical Bulletin

      Volume: 42 Issue: 3 Pages: 411-416

    • DOI

      10.1248/bpb.b18-00722

    • NAID

      130007607154

    • ISSN
      0918-6158, 1347-5215
    • Year and Date
      2019-03-01
    • Related Report
      2019 Annual Research Report 2018 Research-status Report
    • Peer Reviewed / Open Access
  • [Presentation] ヒト培養細胞株を用いた細菌型チロシンキナーゼの発現解析2020

    • Author(s)
      深澤 秀輔
    • Organizer
      日本薬学会第140年会
    • Related Report
      2019 Annual Research Report
  • [Presentation] ヒト培養細胞株を用いた黄色ブドウ菌チロシンキナーゼの解析2019

    • Author(s)
      深澤 秀輔
    • Organizer
      日本薬学会第139年会
    • Related Report
      2018 Research-status Report

URL: 

Published: 2016-04-21   Modified: 2021-02-19  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi